CN Patent

CN111285882B — 稠环化合物、包含其的药物组合物及其制备方法和用途

Assigned to Sichuan Kelun Biotech Biopharmaceutical Co Ltd · Expires 2022-12-02 · 3y expired

What this patent protects

本发明涉及式(I‑A)或式(I‑B)的稠环化合物、包含其的药物组合物、其制备方法及其用于预防或治疗与RET活性相关的疾病或病况。

USPTO Abstract

本发明涉及式(I‑A)或式(I‑B)的稠环化合物、包含其的药物组合物、其制备方法及其用于预防或治疗与RET活性相关的疾病或病况。

Drugs covered by this patent

Patent Metadata

Patent number
CN111285882B
Jurisdiction
CN
Classification
—
Expires
2022-12-02
Drug substance claim
No
Drug product claim
No
Assignee
Sichuan Kelun Biotech Biopharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.